Indoleamine 2,3-Dioxygenase and Regulatory Function: Tryptophan Starvation and Beyond (Q44728735)

5 December 2017

title

Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond (English)

1 reference

5 December 2017

Indoleamine 2,3-Dioxygenase and Regulatory Function: Tryptophan Starvation and Beyond (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

1 August 2024

author name string

Ciriana Orabona

1

1 reference

5 December 2017

Ursula Grohmann

2

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

full work available at URL

5 December 2017

http://link.springer.com/content/pdf/10.1007/978-1-60761-869-0_19

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Methods in Molecular Biology

1 August 2024

published in

1 reference

5 December 2017

volume

677

1 reference

5 December 2017

page(s)

269-280

1 reference

Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.

5 December 2017

cites work

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1038/NATURE06471

IDO expression by dendritic cells: tolerance and tryptophan catabolism

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1038/NRI1457

3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.0709261104

Prevention of allogeneic fetal rejection by tryptophan catabolism

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1126/SCIENCE.281.5380.1191

Inhibition of experimental asthma by indoleamine 2,3-dioxygenase

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI21275

Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase

4

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO).

1 August 2024

6

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Tryptophan metabolites interfere with the Ehrlich reaction used for the measurement of kynurenine

1 August 2024

8

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells.

1 August 2024

9

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

TGF-beta and kynurenines as the key to infectious tolerance

1 August 2024

10

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes

1 August 2024

11

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells

1 August 2024

12

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition

1 August 2024

13

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism.

1 August 2024

14

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

CTLA-4-Ig regulates tryptophan catabolism in vivo.

1 August 2024

15

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Modulation of tryptophan catabolism by regulatory T cells.

1 August 2024

16

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.

1 August 2024

17

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant.

1 August 2024

18

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

1 August 2024

19

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

1 August 2024

20

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12.

1 August 2024

21

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.

1 August 2024

22

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis

1 August 2024

23

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.

1 August 2024

24

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Crystal structure and mechanism of tryptophan 2,3-dioxygenase, a heme enzyme involved in tryptophan catabolism and in quinolinate biosynthesis

1 August 2024

25

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells

1 August 2024

26

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

1 August 2024

27

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice

1 August 2024

28

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite

1 August 2024

29

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice

1 August 2024

30

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

4-1BB-mediated immunotherapy of rheumatoid arthritis.

1 August 2024

31

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection

1 August 2024

32

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 August 2024

34

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

1 August 2024

35

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology

1 August 2024

36

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells

1 August 2024

37

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Immunology: A metabolic switch to memory.

1 August 2024

38

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Immunology. Amino acid addiction.

1 August 2024

39

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.

1 August 2024

40

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

1 August 2024

41

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Infectious tolerance via the consumption of essential amino acids and mTOR signaling

1 August 2024

42

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Tolerance, DCs and tryptophan: much ado about IDO

1 August 2024

43

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO

1 August 2024

45

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

1 August 2024

46

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation

1 August 2024

47

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?

1 August 2024

48

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.

1 August 2024

49

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?

1 August 2024

50

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques

1 August 2024

51

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice

1 August 2024

52

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice

1 August 2024

53

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis.

1 August 2024

54

1 reference

https://api.crossref.org/works/10.1007/978-1-60761-869-0_19

1 August 2024

Identifiers

1 reference

5 December 2017

1 reference